China NT Pharma Group Co Ltd

HKSE • Healthcare • Diagnostics & Research • Quote as of 10/30/2026

Company Profile

IndustryDiagnostics & Research

SectorHealthcare

ExchangeHKSE

Market Capitalization449.14 mln

Float1,379 mln

Earnings Date04/01/2027

Piotroski F-Score

5 / 9

Neutral

Beneish M-Score

-0.69

Highly suspicious

Relative Strength

15 / 100

Significantly lagging

Pre-Tax Margin

-72%

Severely loss-making

ROE

14.19

Moderate

Altman Z-Score

-11.71

Deeply distressed

Business Description

Founded in 1995 and based in Hong Kong, China NT Pharma Group is a pharmaceutical company operating across mainland China. The company sells and distributes medical products on behalf of its clients, including prescription medicines and AI-powered bone density testing tools. It also runs health education and research programs focused on bone health.

Key Fundamentals

EPS-0.04

ROE14.19

RPS0.05

ROIC-1.30

ROA-6.17

Interest Cover-0.54

EBITDA, mln1.11

EV / EBITDA1,014

EV / EBIT21,649

Revenue, mln40.29

EV / Revenue27.94

Quote Details

Last 0.245

Change -0.02 (-7.55%)

Open 0.29

Volume 161,000

Turnover 39,445

Average Volume 240,966

Financial Ratios

Pre-Tax Profit Margin-72

Current Ratio0.05

Price / Sales7.74

Financial Strength

Altman Z-Score-11.71

Piotroski F-Score 5 / 9

Beneish M-Score-0.69

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-5.77%	23 / 100
1 Month	-36.36%	4 / 100
2 Months	-43.02%	7 / 100
6 Months	-67.76%	4 / 100
1 Year	-68.99%	8 / 100